GET THE APP

In-house Modification and Improvement of the CDC Realtime PCR Diagnostic Assay for SARS-CoV-2 Detection

Journal of Diagnostic Techniques and Biomedical Analysis.ISSN: 2469-5653

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

In-house Modification and Improvement of the CDC Realtime PCR Diagnostic Assay for SARS-CoV-2 Detection

Objective: The world is currently facing an unprecedented pandemic caused by the novel coronavirus SARS-CoV-2 (COVID-19) which was first reported in late 2019 by China to the World Health Organization (WHO). The containment strategy for COVID-19, which has non-specific flu-like symptoms and where upwards of 80% of the affected has either mild or no symptoms, is critically centered upon diagnostic testing, tracking and isolation. Thus, the development of specific and sensitive diagnostic tests for COVID-19 is key towards the first successful step of disease management.
Methods: Public health organizations like the WHO and the US-based Centers for Disease Control and Prevention (CDC) have developed real-time PCR (RT-PCR) based diagnostic
tests to aid in the detection of acute infection. In this study we sought to modify the CDC RT-PCR diagnostic assay protocol to increase its sensitivity and to make the assay directly portable to health care providers in a community-based hospital setting. 
Results: A number of modifications to the original protocol were tested. Increasing the RT-PCR annealing temperature by 7°C to 62°C was associated with the most significant
improvement in sensitivity, wherein the Cycle-threshold (Ct) value for the N2 assay was reduced by ~ 3 units, in effect both reducing the overall number of inconclusive results and yielding
N1/N2 assays to have similar Ct values. The limit of detection of the modified assay was also improved (0.86 RNA copies/μl for both nCoV 2019_N1/N2 assays) compared to the CDC RTPCR diagnostic assay (1 and 3.16 RNA copies/μl for nCoV 2019_N1 and N2 assay, respectively). Using this modification, there was no significant effect on SARS-CoV-2 detection rate
when viral RNA extraction was performed either manually or through an automated extraction method.
Conclusion: We believe this modified protocol allows for more sensitive detection of the virus which in turn will be useful for pandemic management.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations